624 Results
Guidelines and Advice
Status: Current
ID: GL-C50-32
ID: GL-C50-32
Jan 2021
Symptom Management
Symptom Management
Symptom Management
Drug
Jul 2020
Drug
Jan 2025
Drug
Dec 2024
Drug
Aug 2025
Drug
Apr 2023
Drug
Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™
Sep 2025
